Month: May 2025

Discussion in Virtual Investor CEO Connect focuses on Company’s planned follow-on market expansion study phase (“PoC 2”) of proof-of-concept trial; Access Here Additional indications potentially double the addressable market beyond pancreatic cancer pain Follow-on expansion phase expected to begin in Q2 2025 THE WOODLANDS, TX, May 13, 2025 (GLOBE NEWSWIRE) — – Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today reiterated its plans for a follow-on phase to its proof-of-concept human clinical trial (“PoC 2”) evaluating the safety and effectiveness of delivering transvascular energy to ablate relevant problematic nerves and mitigate cancer pain. Additionally,...

— AMD EPYC 4005 Processors provide a compelling balance of performance, dependability and efficiency in an affordable, easy-to-deploy platform — SANTA CLARA, Calif., May 13, 2025 (GLOBE NEWSWIRE) — AMD (NASDAQ: AMD) today announced the launch of AMD EPYC™ 4005 Series processors. These purpose-built processors enable right-sized solutions with enterprise-class features and leadership performance for small and medium businesses and hosted IT service providers. AMD EPYC 4005 Series CPUs deliver the performance, features and efficiency growing businesses need to power everything from enterprise applications and virtualized environments to dedicated, all-day hosted services in the cloud. Utilizing the same proven and widely deployed AM5 socket used for the AMD EPYC 4004 Series CPUs, the EPYC 4005 Series delivers an innovative...

– Expect to report topline data from the Seabreeze STAT Asthma study in 1H 2026 – – On track to initiate similarly-designed Phase 2 study in patients with COPD imminently – SAN DIEGO, May 13, 2025 (GLOBE NEWSWIRE) — Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect or the Company), a clinical-stage biopharmaceutical company focused on transforming acute and chronic care of asthma and chronic obstructive pulmonary disease (COPD), today announced the initiation of its Phase 2 Seabreeze STAT Asthma study (NCT06940141) following written agreement on the final study protocol from the U.S. Food and Drug Administration. The study will evaluate the safety and efficacy of rademikibart as an adjunct to standard of care for acute exacerbations in adults and adolescent participants with asthma and type 2 inflammation. “We...

GEORGE TOWN, Cayman Islands, May 13, 2025 (GLOBE NEWSWIRE) — Consolidated Water Co. Ltd. (NASDAQ Global Select Market: CWCO), a leading designer, builder and operator of advanced water supply and treatment plants, reported that its wholly owned subsidiary, Kalaeloa Desalco LLC, recently achieved a major milestone for its $204 million project to design, construct, operate and maintain a 1.7 million gallon per day seawater desalination plant in Hawaii. The Honolulu Board of Water Supply, the client for the multi-year project that commenced in June 2023, approved the pilot test reports and recommendations submitted by Kalaeloa Desalco. The Board concluded that the desalinated water the company produced during the piloting phase is a reasonable match to their existing water supply. They also concluded that the desalinated water from...

AI-Powered Workforce Monitoring Tool Developed for Large-Scale, Global Operations Targets Rapidly Expanding Remote Customer Service Industry New Offering Pioneers Intelligent Time Management, Video Monitoring, and Performance Insights Across Borders SINGAPORE and MANILA, Philippines and SAN DIEGO, May 13, 2025 (GLOBE NEWSWIRE) — Helport AI Limited (NASDAQ: HPAI) (“Helport AI” or the “Company”), an AI technology company serving enterprise clients with intelligent customer communication software and services, today announced the launch of Helport Remote, a new workforce monitoring and management tool designed to support the evolving needs of remote contact centers. Engineered specifically for large-scale, multinational contact center operations, Helport Remote aims to empower management teams to achieve greater visibility, control,...

TEL AVIV, Israel, May 13, 2025 (GLOBE NEWSWIRE) — ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace company focused on safety systems for commercial unmanned aircrafts and defense counter-UAS systems, today announced a follow-on purchase order for its innovative SafeAir™ M4 parachute recovery system from a prominent drone technology partner in Europe. This order reflects ParaZero’s growing traction in Europe’s dynamic drone market, a hub for advanced unmanned aerial systems (UAS) in logistics, infrastructure inspection, and public safety. The SafeAir™ M4, ParaZero’s next-generation autonomous parachute recovery system, is designed for seamless integration with DJI’s Matrice 4 series. It features real-time telemetry and is designed and expected to comply with the highest European...